Mitsubishi UFJ Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14K | Hold |
1,001
| – | – | ﹤0.01% | 1277 |
|
|
2025
Q1 | $13.6K | Hold |
1,001
| – | – | ﹤0.01% | 1242 |
|
|
2024
Q4 | $21.3K | Hold |
1,001
| – | – | ﹤0.01% | 1151 |
|
|
2024
Q3 | $29.2K | Hold |
1,001
| – | – | ﹤0.01% | 1072 |
|
|
2024
Q2 | $23.2K | Buy |
1,001
+856
| +590% | +$19.9K | ﹤0.01% | 1077 |
|
|
2024
Q1 | $2.98K | Hold |
145
| – | – | ﹤0.01% | 1528 |
|
|
2023
Q4 | $2.95K | Hold |
145
| – | – | ﹤0.01% | 1528 |
|
|
2023
Q3 | $2.99K | Buy |
+145
| New | +$2.99K | ﹤0.01% | 1494 |
|
|
2018
Q4 | – | Sell |
-1,830
| Closed | -$40K | – | 924 |
|
|
2018
Q3 | $40K | Sell |
1,830
-125
| -6% | -$2.73K | ﹤0.01% | 917 |
|
|
2018
Q2 | $30K | Sell |
1,955
-133
| -6% | -$2.04K | ﹤0.01% | 846 |
|
|
2018
Q1 | $41K | Sell |
2,088
-62
| -3% | -$1.22K | ﹤0.01% | 835 |
|
|
2017
Q4 | $36K | Buy |
+2,150
| New | +$36K | ﹤0.01% | 824 |
|